Simultaneous quantitation of abiraterone, enzalutamide, N-desmethyl enzalutamide, and bicalutamide in human plasma by LC-MS/MS
      QxMD      Google Scholar   
Citation:
J Pharm Biomed Anal vol 138 197-205
Year:
2017
Type:
Manuscript
Funding:
NCTN
Endpoint:
Secondary-not-in-original
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
pmc-release
Note:
Methodological:
No
Biospecimen:
Yes
SDC:
No
Book Volume:
6
Parents:
None
Children:
None
Program:
TRP
Primary Committee:
Correl Sci NOS
Sec. Committees:
GU    
Pharmas:
 
Grants:
P30-CA47904, U10CA180821, CA31946, U10CA004326, U10CA007968, U10CA077651, U10CA180791, U10CA180844, U10CA180854, R50 CA211241, U10 CA007968, P30 CA047904, U10 CA031946, U10 CA180854, U10 CA180821, P30 CA023108, P30 CA008748, U10 CA180791, U10 CA077651, U10 CA180844  
Corr. Author:
 
Authors:
                 
Networks:
LAPS-NH012, LAPS-NY016, LAPS-PA015   
Study
Alliance-A031201
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
3
Keywords:
bicalutamide, enzalutamide, abiraterone, tandem mass spectrometry, metabolites, assay, validation